Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUDARABINE for Neoplasm malignant: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 20 adverse event reports in the FDA FAERS database where FLUDARABINE was used for Neoplasm malignant.

Most Reported Side Effects for FLUDARABINE

Side Effect Reports % Deaths Hosp.
Off label use 3,018 12.8% 814 673
Febrile neutropenia 2,055 8.7% 337 1,096
Drug ineffective 1,630 6.9% 489 532
Pyrexia 1,606 6.8% 361 963
Product use in unapproved indication 1,530 6.5% 382 198
Cytokine release syndrome 1,458 6.2% 238 940
Neutropenia 1,175 5.0% 349 486
Cytomegalovirus infection 1,132 4.8% 300 226
Mucosal inflammation 1,036 4.4% 223 243
Sepsis 981 4.2% 618 403
Thrombocytopenia 975 4.1% 199 399
Cytomegalovirus infection reactivation 917 3.9% 182 184
Pneumonia 867 3.7% 371 436
Pancytopenia 836 3.5% 238 335
Infection 834 3.5% 507 200

Other Indications for FLUDARABINE

Bone marrow conditioning regimen (6,080) Chronic lymphocytic leukaemia (2,777) Allogenic stem cell transplantation (2,008) Acute myeloid leukaemia (1,927) Stem cell transplant (1,601) Product used for unknown indication (1,336) Acute lymphocytic leukaemia (554) B-cell lymphoma (526) Prophylaxis against transplant rejection (524) Immunosuppressant drug therapy (519)

Other Drugs Used for Neoplasm malignant

PALBOCICLIB (1,996) CAPECITABINE (1,493) PEMBROLIZUMAB (1,135) PACLITAXEL (984) CARBOPLATIN (977) NIVOLUMAB (947) OXALIPLATIN (823) PAZOPANIB (716) CYCLOPHOSPHAMIDE (685) FLUOROURACIL (676)

Related Pages

FLUDARABINE Full Profile All Neoplasm malignant Drugs FLUDARABINE Demographics FLUDARABINE Timeline